The 8mg dose produces 21.1% average weight loss compared to 24.2% at 12mg

Retatrutide reconstitution chart Vial Size 5 mg BAC Water 1.0 mL Concentration 5 mg/mL (5,000 mcg/mL) 1 mg 0.20 mL (20 units) 2 mg 0.40 mL (40 units) 4 mg 0.80 mL (80 units) 6 mg Exceeds vial 9 mg Exceeds vial 12 mg Exceeds vial Vial Size 10 mg BAC Water 2.0 mL Concentration 5 mg/mL (5,000 mcg/mL) 1 mg 0.20 mL (20 units) 2 mg 0.40 mL (40 units) 4 mg 0.80 mL (80 units) 6 mg 1.20 mL - split draw or 2 vials 9 mg Requires 2 vials 12 mg Requires 2-3 vials Vial Size 20 mg BAC Water 2.0 mL Concentration 10 mg/mL (10,000 mcg/mL) 1 mg 0.10 mL (10 units) 2 mg 0.20 mL (20 units) 4 mg 0.40 mL (40 units) 6 mg 0.60 mL (60 units) 9 mg 0.90 mL (90 units) 12 mg 1.20 mL - split draw Vial Size 24 mg BAC Water 2.4 mL Concentration 10 mg/mL (10,000 mcg/mL) 1 mg 0.10 mL (10 units) 2 mg 0.20 mL (20 units) 4 mg 0.40 mL (40 units) 6 mg 0.60 mL (60 units) 9 mg 0.90 mL (90 units) 12 mg 1.20 mL - split draw Vial Size 30 mg BAC Water 3.0 mL Concentration 10 mg/mL (10,000 mcg/mL) 1 mg 0.10 mL (10 units) 2 mg 0.20 mL (20 units) 4 mg 0.40 mL (40 units) 6 mg 0.60 mL (60 units) 9 mg 0.90 mL (90 units) 12 mg 1.20 mL - split draw Units are U-100 insulin syringe units (1 mL = 100 units)

[10] [11] Patients prescribed GLP-1 medications receive comprehensive support, including education about administration technique, management of common side effects (such as nausea, which often improves over time), and monitoring for efficacy and safety
S., Brndsted, L., Kankam, M., et al